Journal Article > CommentaryFull Text
Lancet Respir Med. 2020 September 1; Volume 8 (Issue 9); 844-846.; DOI:10.1016/S2213-2600(20)30311-8
Keene CM, Mohr-Holland E, Cassidy T, Scott V, Nelson AM, et al.
Lancet Respir Med. 2020 September 1; Volume 8 (Issue 9); 844-846.; DOI:10.1016/S2213-2600(20)30311-8
Journal Article > LetterFull Text
Int J Tuberc Lung Dis. 2021 May 1; Volume 25 (Issue 5); 409-412.; DOI:10.5588/ijtld.21.0010
Mohr-Holland E, Daniels J, Douglas-Jones B, Mema N, Scott V, et al.
Int J Tuberc Lung Dis. 2021 May 1; Volume 25 (Issue 5); 409-412.; DOI:10.5588/ijtld.21.0010
Journal Article > CommentaryFull Text
Lancet Respir Med. 2022 March 1; Volume S2213-2600 (Issue 22); 00121-7.; DOI:10.1016/S2213-2600(22)00121-7
Apolisi I, Mema N, Tyeku N, Beko B, Memani B, et al.
Lancet Respir Med. 2022 March 1; Volume S2213-2600 (Issue 22); 00121-7.; DOI:10.1016/S2213-2600(22)00121-7
Journal Article > ResearchFull Text
Public Health Action. 2022 June 21; Volume 12 (Issue 2); 55-57.; DOI:10.5588/pha.21.0083
Memani B, Beko B, Dumile N, Mohr-Holland E, Daniels J, et al.
Public Health Action. 2022 June 21; Volume 12 (Issue 2); 55-57.; DOI:10.5588/pha.21.0083
Patients initiated on drug-resistant TB (DR-TB) treatment in 2019 in Khayelitsha, South Africa, with a loss to follow-up outcome were evaluated to better understand reasons for loss to follow-up and to determine if any had returned to care. Of a total of 187 patients, 28 (15%) were lost to follow-up (LTFU), 24 (86%) of whom were traced: 20/24 (83%) were found when they re-presented to facilities and 8/28 (29%) were linked back to DR-TB care. People with DR-TB continue to seek care even after being LTFU; thus better coordination between different components of the healthcare system are required to re-engage with these patients. Interventions to mitigate the socio-economic challenges of people on DR-TB treatment are needed. Many people who were LTFU and symptomatic were willing to re-engage with DR-TB care, which highlights the importance of for compassionate interventions to welcome them back.
Journal Article > LetterFull Text
Int J Tuberc Lung Dis. 2021 July 1; Volume 25 (Issue 7); 587-589.; DOI:10.5588/ijtld.21.0051
Douglas-Jones B, Mohr-Holland E, Mema N, Mathee S, Mathews G, et al.
Int J Tuberc Lung Dis. 2021 July 1; Volume 25 (Issue 7); 587-589.; DOI:10.5588/ijtld.21.0051
Journal Article > LetterFull Text
Int J Tuberc Lung Dis. 2021 September 1; Volume 25 (Issue 9); 772-775(4).; DOI:10.5588/ijtld.21.0340
Mohr-Holland E, Hacking D, Daniels J, Scott V, Mudaly V, et al.
Int J Tuberc Lung Dis. 2021 September 1; Volume 25 (Issue 9); 772-775(4).; DOI:10.5588/ijtld.21.0340